Department report outlines concerns about long-term effects of medical interventions for minors.
The U.S. Department of Health and Human Services (HHS) recently released a peer-reviewed report examining available evidence on medical interventions for minors diagnosed with gender dysphoria. The study, published through the Office of the Assistant Secretary for Health, stated that treatments such as puberty blockers, cross-sex hormones, and certain surgical procedures may pose significant and long-term health risks.
Federal health officials, including Secretary Robert F. Kennedy, Jr., NIH Director Jay Bhattacharya, and Assistant Secretary Brian Christine, emphasized their view that current practices have not sufficiently accounted for these concerns.
“This report marks a turning point for American medicine,” said Director Bhattacharya. “The evidence in it meticulously documents the risks the profession has imposed on vulnerable children. At the NIH, we are committed to ensuring that science, not ideology, guides America’s medical research.”
The report included contributors from medicine, psychology, bioethics, and related fields. Officials noted that major medical associations were invited to participate but declined. According to the department, the findings are intended to inform federal policy and future research priorities regarding clinical care for minors. The review builds on earlier work commissioned by HHS to assess both scientific evidence and patterns of clinical decision-making.
As the Lord Leads, Pray with Us…
- For Secretary Kennedy, Director Bhattacharya, and Assistant Secretary Christine as they oversee research, reporting, and regulatory determinations that affect children and families.
- For U.S. health researchers as they evaluate and communicate emerging evidence to uphold safe and ethical standards in medical practice.
- For young people and families navigating gender dysphoria to receive accurate information and beneficial support.
Sources: Department of Health and Human Services
